Tuesday, October 4, 2011

Login People® Will Introduce “the Digital DNA Technology®” at GITEX Technology Week 9-13 October 2011


SOPHIA ANTIPOLIS, France - Tuesday, October 4th 2011 [ME NewsWire]

GITEX 2011

(BUSINESS WIRE)-- Login People (Paris:MLLP), “the Digital DNA technology®” software editor, which provides innovative access control solutions to private and public networks, has announced today that it will introduce his technology at GITEX technology week in Dubai from 9 to 13 October.

Login People® is the creator of the Digital DNA Technology®. The company supplies an innovative strong authentication solution in order to secure the access of users to public and private networks (Extranet, VPN SSL, webmail, etc.).

The Digital DNA Technology® allows users to authenticate themselves with "what they know" (a PIN code) and "what they own" (their own equipment such as their computer, smartphone or USB key). The user chooses the equipment he wishes to use for authentication.

Login People® provides a technological answer to the weakness of the "Login / Password" and solves the issues related to identity theft, password sharing and personal or sensitive data theft on every network.

Presentations will be held at the French Pavilion at Sheikh Saeed Hall, booth TA-F30. The company is looking for integrators and resellers in the field of strong authentication for banking, healthcare and B2B internet services providers.

For any further information, please visit www.loginpeople.com

SOPHIA ANTIPOLIS . PARIS . NEW YORK . SAN FRANCISCO

www.loginpeople.com| info@loginpeople.com| NYSE Euronext : MLLP

LoginPeople France - S.A. au capital de 1 125 998,71 € | RCS Grasse B453639932 SIRET 453 639 932 00038 - NAF 6201Z | Siège social : Buropolis - 1240 route des Dolines - SOPHIA ANTIPOLIS - F-06560 Valbonne

Buropolis - 1240 route des Dolines

SOPHIA ANTIPOLIS - F-06560 Valbonne

Tél. : +33 493 330 666 | Fax : +33 493 675 845

Contacts

Login People

Olivier AZAN

+33(0)4 93 33 06 66

olivier.azan@loginpeople.com

No comments:

Post a Comment